Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults-Reference-Cited by-同舟云学术

Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults

Published:2017-07-19 Issue:3 Volume:3 Page:471-479
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Chuang Yi-Fang¹²³,Elango Palchamy⁴,Gonzalez Christopher E.⁵,Thambisetty Madhav¹

Affiliation:

1. Clinical and Translational Neuroscience Unit; Laboratory of Behavioral Neuroscience, National Institute on Aging; Baltimore MD USA

2. Institute of Public Health, National Yang-Ming University; Taipei Taiwan

3. Department of Psychiatry; Far Eastern Memorial Hospital; New Taipei City Taiwan

4. Longitudinal Studies Section, Translational Gerontology Branch, Intramural Research Program; National Institute on Aging; Baltimore MD USA

5. Laboratory of Behavioral Neuroscience, National Institute on Aging; Baltimore MD USA

Funder

Intramural Research Program

National Institute on Aging

National Institutes of Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

Reference53 articles.

5. Anticholinergic effects of medication in elderly patients;Tune;J Clin Psychiatry,2001

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献